SUBSCRIBE
SUBSCRIBE
News   Business

Dow AgroSciences LLC Inks Biotech Deal with Sangamo BioSciences, Inc.

June 19, 2008 | 
1 min read
SAN DIEGO, JUNE 18 (Reuters) - Dow AgroSciences, a unit of Dow Chemical Co. said on Wednesday it had exercised its option to obtain a commercial license for "zinc finger" technology from Sangamo BioSciences.
Alliances
Sangamo Therapeutics, Inc.
MORE ON THIS TOPIC
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Novartis Continues Cutting Spree With 58 Sacked in New Jersey
September 3, 2025
 · 
195 min read
 · 
BioSpace Editorial Staff
Building a rocket. Halftone hands assemble a rocket shaped puzzle. Concept of a startup, new business. Hasty rocket launch. Innovation, teamwork, development of ideas and technologies
Deals
Vertex, Enlaza Declare War on Autoimmune Disease in Potential $2B+ Pact
September 2, 2025
 · 
2 min read
 · 
Heather McKenzie
Exeternal view of the Servier's headquarters in France
Cancer
Servier Commits up to $530M Into Eye Cancer Deal With IDEAYA
September 2, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Illustration showing a handshake, signaling cooperation, goodwill
Deals
Arrowhead Nabs up to $2B Novartis Commitment for siRNA Parkinson’s Program
September 2, 2025
 · 
1 min read
 · 
Annalee Armstrong